Biolex Therapeutics was a biotechnology firm in the Research Triangle of North Carolina which was founded in 1997 and raised $190 million from investors. It filed for Chapter 7 bankruptcy …

Jul 9, 2012 · Biolex Therapeutics is calling it quits after burning through $190 million of venture cash from a slate of top-tier biopharma players on a once-promising hepatitis C drug.

Biolex is a clinical-stage biopharmaceutical company that uses their patented LEX SystemSM to develop hard-to-make therapeutic proteins and monoclonal antibodies that have been …

The LEX System gives Biolex the ability to develop a therapeutic protein from the primary amino acid sequence through a scale-up of purified cGMP product suitable for clinical trials and …

Jan 7, 2025 · Learn about Biolex uses, dosage, side effects, food interactions, and more. Get all the details about Biolex from MedicinesFAQ.

A randomized double-blind placebo-controlled trial to investigate the effectiveness and safety of a novel green-lipped mussel extract -BioLex® -for managing pain in moderate to severe …

Dr. David J. Bearss is a trendsetting entrepreneur of drug development with over 20 years’ of experience. Not only is David an industry-leading expert in small molecule drug development …

Biolex is a clinical-stage biopharmaceutical company that uses its patented LEX System(SM) to develop hard-to-make therapeutic proteins and to optimize monoclonal antibodies. The LEX …

Feb 27, 2025 · Biolex® MB40 represents a scientifically validated prebiotic supplement for supporting canine digestive health through multiple complementary mechanisms. Its premium …

And since 1998, Pittsboro, North Carolina-based Biolex, Inc. has been taking this technology into a new arena: plant-based production of hard-to-make proteins, such as peptides, cytokines, …